Bafna Pharmaceuticals Ltd | Scrip Code : 532989 | Quarter ending :September 2019 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | Yes | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 8 | 62,35,865 | 62,35,865 | 26.36 | 62,35,865 | 26.36 | | 0.00 | 31,82,556 | 51.04 | 62,35,865 | - | - | - | (B) Public | 8,645 | 1,74,20,470 | 1,74,20,470 | 73.64 | 1,74,20,470 | 73.64 | 50,12,077 | 28.77 | | 0.00 | 1,73,40,021 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 8,653 | 2,36,56,335 | 2,36,56,335 | 100.00 | 2,36,56,335 | 100.00 | 50,12,077 | 21.19 | 31,82,556 | 13.45 | 2,35,75,886 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|